Please use this identifier to cite or link to this item: https://repository.unej.ac.id/xmlui/handle/123456789/87511
Title: Pengaruh Pemberian Galaktomanan dari Daging Kelapa Lokal (Cocos nufitera L) terhadap Kadar Glucagon Like Peptide-1 (GLP-1) pada Tikus Wistar Jantan yang Hiperkolesterolemia (Effect of Galactomannan from Local Coconut (Cocos nufitera L) on Glucagon Like Peptide-1 (GLP-1) in Hypercholesterolemia Rats)
Authors: Aulia, Inayatul
Subagio, Achmad
Prasetyo, Aris
Keywords: Hypercholesterolemia
GLP-1
Galactomannan
Simvastatin
Issue Date: 2-Oct-2018
Abstract: Hypercholesterolemia is a condition characterized by high cholesterol concentration in blood. This is a risk factor for many diseases. Glucagon Like Peptide-1 (GLP-1) is an incretin hormone that affects cholesterol and other diseases with hypercholesterolemia as a risk factor. Drug that widely used for hypercholesterolemia is simvastatin which can increase GLP-1. GLP-1 also can be increased by high fibrous foods consumption, one of which is galactomannan which can be found in coconut as much as 61%. This study aimed to determine the effect of galactomannan on GLP-1 and compared with simvastatin. Wistar rats were induced into hypercholesterolemia and than treated with galactomannan 70 mg/200gBW/day and 140 mg/200gBW/day and simvastatin 0,1 mg/200gBW/day. After 28 days, GLP-1 levels was measured. The result showed that GLP-1 in 140 mg/200gBW/day group was the highest and in 70 mg/200gBW/day group was the lowest. Data analysis revealed no significant difference between 140 mg/200gBW/day and simvastatin group. In conclusion, galactomannan 140 mg/200gBW/day had the same potency as simvastatin 0,1 mg/200gBW/day.
Description: e-Jurnal Pustaka Kesehatan, vol. 2 (no. 2), Mei 2014
URI: http://repository.unej.ac.id/handle/123456789/87511
ISSN: 2355-178X
Appears in Collections:LSP-Jurnal Ilmiah Dosen

Files in This Item:
File Description SizeFormat 
F. K_Jurnal_Aris P_Pengaruh Pemberian Galaktomanan.pdf148.85 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.